AbstractRadiotherapy is the most successful nonsurgical treatment for nasopharyngeal carcinoma (NCP). Although NPCs initially respond well to a full course of radiation, recurrence and metastasis are frequent. In this study, we found that down-regulated c-MYB expression was associated with increased radiation resistance and DNA damage repair ability. Interestingly, c-MYB was over-expressed in cancer tissues but not in the adjacent tissues. Down-regulation of c-MYB expression inhibited cell proliferation, and led to cell cycle arrest at the M phase in NPC cells. Luciferase and chromatin immunoprecipitation assays demonstrated that c-MYB transactivated miR-143 through direct binding to its promoter. Based on these results, c-MYB might target ...
c-Myc has a pivotal function in the development of breast cancer. Our data show that decreasing the ...
Advanced breast cancer cells acquire metastatic properties in response to TGF-β. We show here that t...
Background:MicroRNAs (miRNAs) are 19-25-nucleotides regulatory non-protein-coding RNA molecules that...
AbstractRadiotherapy is the most successful nonsurgical treatment for nasopharyngeal carcinoma (NCP)...
BACKGROUND: With current treatment strategies, nearly half of all medulloblastoma (MB) patients die ...
c-Myc is a transcriptional factor that functions as a central regulator of cell growth, proliferatio...
AbstractDysregulated expression of MYC family genes is a hallmark of many malignancies. Unfortunatel...
Transfection of a neuroblastoma cell line with expression vectors containing two different segments ...
Abstract Background miR-141 is up-regulated and plays crucial roles in nasopharyngeal carcinoma (NPC...
Expression of the c-myb proto-oncogene is primarily detected in normal tissue and tumor cell lines o...
Nasopharyngeal carcinoma (NPC) is the type of cancer related to multiple risk factors, including inf...
AbstractNon-small cell lung cancer (NSCLC) is one of the most common causes for lung cancer and canc...
c-Myb is a transcription factor employed in the haematopoietic system and gastrointestinal tract to ...
Recent studies have suggested that C-MYC may be an excellent therapeutic cancer target and a number ...
Haploinsufficiency of chromosome 17p and c-Myc amplification distinguish group 3 medulloblastomas wh...
c-Myc has a pivotal function in the development of breast cancer. Our data show that decreasing the ...
Advanced breast cancer cells acquire metastatic properties in response to TGF-β. We show here that t...
Background:MicroRNAs (miRNAs) are 19-25-nucleotides regulatory non-protein-coding RNA molecules that...
AbstractRadiotherapy is the most successful nonsurgical treatment for nasopharyngeal carcinoma (NCP)...
BACKGROUND: With current treatment strategies, nearly half of all medulloblastoma (MB) patients die ...
c-Myc is a transcriptional factor that functions as a central regulator of cell growth, proliferatio...
AbstractDysregulated expression of MYC family genes is a hallmark of many malignancies. Unfortunatel...
Transfection of a neuroblastoma cell line with expression vectors containing two different segments ...
Abstract Background miR-141 is up-regulated and plays crucial roles in nasopharyngeal carcinoma (NPC...
Expression of the c-myb proto-oncogene is primarily detected in normal tissue and tumor cell lines o...
Nasopharyngeal carcinoma (NPC) is the type of cancer related to multiple risk factors, including inf...
AbstractNon-small cell lung cancer (NSCLC) is one of the most common causes for lung cancer and canc...
c-Myb is a transcription factor employed in the haematopoietic system and gastrointestinal tract to ...
Recent studies have suggested that C-MYC may be an excellent therapeutic cancer target and a number ...
Haploinsufficiency of chromosome 17p and c-Myc amplification distinguish group 3 medulloblastomas wh...
c-Myc has a pivotal function in the development of breast cancer. Our data show that decreasing the ...
Advanced breast cancer cells acquire metastatic properties in response to TGF-β. We show here that t...
Background:MicroRNAs (miRNAs) are 19-25-nucleotides regulatory non-protein-coding RNA molecules that...